Publication date: Available online 18 June 2013
Source:Progress in Retinal and Eye Research
Author(s): Trevor D. Lamb
Evidence is reviewed from a wide range of studies relevant to the evolution of vertebrate photoreceptors and phototransduction, in order to permit the synthesis of a scenario for the major steps that (Read more...)
Systemic Therapies for Inflammatory Eye Disease
What advancements are being made in the systemic treatment of inflammatory eye disease? BMC Ophthalmology
New Medication May Improve Sleep in Blind People
A phase 3 study shows that tasimelteon can improve symptoms in blind people who experience sleep disruption due to a circadian-rhythm disorder. Medscape Medical News
Reading speed improves in patients with RVO after anti-VEGF injections
Monthly injections of ranibizumab improved reading speed in patients with macular edema secondary to retinal vein occlusion, according to a study.The analysis was derived from the 789 patients with branch or central retinal vein occlusion who took part in the multicenter, double-masked phase 3 BRAVO and CRUISE trials.Sham treatments were administered to 132 BRAVO patients and 130 CRUISE patients; intravitreal injections of Lucentis 0.3 mg (ranibizumab, Genentech) were administered to 134 BRAVO patients and 132 CRUISE patients; and intravitreal injections of ranibizumab 0.5 mg were administered to 131 BRAVO patients and (Read more...)
Argon laser photoablation may treat superficial conjunctival nevus
Argon laser photoablation may be used to treat superficial conjunctival nevus instead of surgical excision, according to a study.
Visian ICL with CentraFLOW gains regulatory approval in Argentina, Korea
Korea and Argentina have granted regulatory approvals to STAAR Surgical to market the Visian Implantable Collamer Lens with CentraFLOW technology, according to a press release.